Recent News
- Epocal Announces FDA Clearance of Lactate Test
OTTAWA, Canada, June 15 /PRNewswire/ -- Epocal, Inc., a leading edge provider of point of care technology, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market its new lactate test on the epoc Blood Analysis System.
- View Full Article
- Tioga Pharmaceuticals Begins Phase 3 Trial of Asimadoline in Irritable Bowel Syndrome
San Diego, Calif. - June 3, 2010 - Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominat irritable bowel syndrome (D-IBS).
- Download the article
- Allostera Pharma Inc. Appoints Christopher Henney As Chairman of its Board of Directors
Montreal, Quebec, Canada. May 19, 2010 -- Allostera Pharma Inc. today announced it has appointed Christopher Henney, PhD, as Chairman of its Board of Directors.
- View Full Article
- NeurAxon, Inc. to Make Multiple Presentations at the International Symposium on Nitric Oxide and Other
Waltham, MA. May 18, 2010 - NeurAxon Inc. today announced several scientific presentations by officers and advisors to the Company at the International Symposium on Nitric Oxide and Other Gaseous Neurotransmitters, May 27 - 28, 2010 in Toronto, Ontario.
- View Full Article
- Affinium Pharmaceuticals, Ltd. Announces the Initiation of a Phase 1 Clinical Trial Using an Optimized Oral Formulation
Austin, Texas, April 9, 2010 - Affinium Pharmaceuticals announced today the commencement of a Phase I study in the United States for its novel molecular entity, AFN-1252, a first in class antibiotic candidate focused on the oral and IV treatment of susceptible and highly resistant strains of Staphylococcus aureus (MRSA)....
- View Full Article